Login / Signup

Comparison of Hormone-Sensitive Oligorecurrent Prostate Cancer Patients Based on Routine Use of Choline and/or PSMA PET/CT to Guide Metastasis-Directed Therapy.

Raphaël MetzAurore RauscherLoig VaugierStéphane SupiotFranck DrouetLoic CampionCaroline Rousseau
Published in: Cancers (2023)
Routine use of FCH or PSMA PET/CT in hormone-sensitive PC showed an advantage for using PSMA PET/CT to guide MDT in terms of BR-FS and ADT-FS in patients with low PSA value. Prospective studies are needed to confirm these hypotheses.
Keyphrases
  • pet ct
  • prostate cancer
  • positron emission tomography
  • clinical practice
  • stem cells
  • radical prostatectomy
  • computed tomography
  • benign prostatic hyperplasia
  • smoking cessation
  • clinical evaluation